However, there is a possibility that the escape of Gd3+ from its chelating cages of the clinically used formulations utilized for contrast-enhanced MRI would modulate TRPC5 activity in breast cancer cells to promote breast cancer cell chemoresistance. The gene discussed is TRPC5; the disease is breast carcinoma.